Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
27,461
archived clinical trials in
Hematology

UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy
UARK 98-026, Total Therapy II - A Phase III Study for Newly Diagnosed Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy
Status: Enrolling
Updated:  10/21/2015
University of Arkansas for Medical Sciences/MIRT
mi
from
Little Rock, AR
UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy
UARK 98-026, Total Therapy II - A Phase III Study for Newly Diagnosed Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy
Status: Enrolling
Updated: 10/21/2015
University of Arkansas for Medical Sciences/MIRT
mi
from
Little Rock, AR
Click here to add this to my saved trials
Efficacy and Safety of Simtuzumab in Adults With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis
A Phase 2 Study to Evaluate the Efficacy and Safety of GS-6624 in Adult Subjects With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis
Status: Enrolling
Updated:  10/22/2015
Stanford Univ Med Ctr
mi
from
Stanford, CA
Efficacy and Safety of Simtuzumab in Adults With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis
A Phase 2 Study to Evaluate the Efficacy and Safety of GS-6624 in Adult Subjects With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis
Status: Enrolling
Updated: 10/22/2015
Stanford Univ Med Ctr
mi
from
Stanford, CA
Click here to add this to my saved trials
Efficacy and Safety of Simtuzumab in Adults With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis
A Phase 2 Study to Evaluate the Efficacy and Safety of GS-6624 in Adult Subjects With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis
Status: Enrolling
Updated:  10/22/2015
Oncology Hematology Care Clinical Trials
mi
from
Cincinnati, OH
Efficacy and Safety of Simtuzumab in Adults With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis
A Phase 2 Study to Evaluate the Efficacy and Safety of GS-6624 in Adult Subjects With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis
Status: Enrolling
Updated: 10/22/2015
Oncology Hematology Care Clinical Trials
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Efficacy and Safety of Simtuzumab in Adults With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis
A Phase 2 Study to Evaluate the Efficacy and Safety of GS-6624 in Adult Subjects With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis
Status: Enrolling
Updated:  10/22/2015
Cleveland Clinic
mi
from
Cleveland, OH
Efficacy and Safety of Simtuzumab in Adults With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis
A Phase 2 Study to Evaluate the Efficacy and Safety of GS-6624 in Adult Subjects With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis
Status: Enrolling
Updated: 10/22/2015
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Efficacy and Safety of Simtuzumab in Adults With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis
A Phase 2 Study to Evaluate the Efficacy and Safety of GS-6624 in Adult Subjects With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis
Status: Enrolling
Updated:  10/22/2015
Utah University
mi
from
Salt Lake City, UT
Efficacy and Safety of Simtuzumab in Adults With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis
A Phase 2 Study to Evaluate the Efficacy and Safety of GS-6624 in Adult Subjects With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis
Status: Enrolling
Updated: 10/22/2015
Utah University
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Efficacy and Safety of Simtuzumab in Adults With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis
A Phase 2 Study to Evaluate the Efficacy and Safety of GS-6624 in Adult Subjects With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis
Status: Enrolling
Updated:  10/22/2015
Mayo Clinic
mi
from
Scottsdale, AZ
Efficacy and Safety of Simtuzumab in Adults With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis
A Phase 2 Study to Evaluate the Efficacy and Safety of GS-6624 in Adult Subjects With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis
Status: Enrolling
Updated: 10/22/2015
Mayo Clinic
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Efficacy and Safety of Simtuzumab in Adults With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis
A Phase 2 Study to Evaluate the Efficacy and Safety of GS-6624 in Adult Subjects With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis
Status: Enrolling
Updated:  10/22/2015
University of California, San Diego
mi
from
San Diego, CA
Efficacy and Safety of Simtuzumab in Adults With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis
A Phase 2 Study to Evaluate the Efficacy and Safety of GS-6624 in Adult Subjects With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis
Status: Enrolling
Updated: 10/22/2015
University of California, San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Efficacy and Safety of Simtuzumab in Adults With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis
A Phase 2 Study to Evaluate the Efficacy and Safety of GS-6624 in Adult Subjects With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis
Status: Enrolling
Updated:  10/22/2015
Washington University, St. Louis
mi
from
St. Louis, MO
Efficacy and Safety of Simtuzumab in Adults With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis
A Phase 2 Study to Evaluate the Efficacy and Safety of GS-6624 in Adult Subjects With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis
Status: Enrolling
Updated: 10/22/2015
Washington University, St. Louis
mi
from
St. Louis, MO
Click here to add this to my saved trials
Efficacy and Safety of Simtuzumab in Adults With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis
A Phase 2 Study to Evaluate the Efficacy and Safety of GS-6624 in Adult Subjects With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis
Status: Enrolling
Updated:  10/22/2015
Tennessee Oncology, PLLC
mi
from
Nashville, TN
Efficacy and Safety of Simtuzumab in Adults With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis
A Phase 2 Study to Evaluate the Efficacy and Safety of GS-6624 in Adult Subjects With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis
Status: Enrolling
Updated: 10/22/2015
Tennessee Oncology, PLLC
mi
from
Nashville, TN
Click here to add this to my saved trials
Efficacy and Safety of Simtuzumab in Adults With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis
A Phase 2 Study to Evaluate the Efficacy and Safety of GS-6624 in Adult Subjects With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis
Status: Enrolling
Updated:  10/22/2015
M.D. Anderson Cancer Center
mi
from
Houston, TX
Efficacy and Safety of Simtuzumab in Adults With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis
A Phase 2 Study to Evaluate the Efficacy and Safety of GS-6624 in Adult Subjects With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis
Status: Enrolling
Updated: 10/22/2015
M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
A Phase II Open-Label Study of High-Dose Cytarabine and Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Refractory or Relapsed Acute Lymphoblastic Leukemia
A Phase II Open-Label Study of High-Dose Cytarabine and Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Refractory or Relapsed Acute Lymphoblastic Leukemia
Status: Enrolling
Updated:  10/22/2015
Wake Forest University Comprehensive Cancer Center
mi
from
Winston-Salem, NC
A Phase II Open-Label Study of High-Dose Cytarabine and Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Refractory or Relapsed Acute Lymphoblastic Leukemia
A Phase II Open-Label Study of High-Dose Cytarabine and Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Refractory or Relapsed Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 10/22/2015
Wake Forest University Comprehensive Cancer Center
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
UARK 2006-28 Human Cord Blood Transplantation in Advanced Hematological Malignancies
UARK 2006-28 Human Cord Blood Transplantation in Advanced Hematological Malignancies
Status: Enrolling
Updated:  10/23/2015
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
UARK 2006-28 Human Cord Blood Transplantation in Advanced Hematological Malignancies
UARK 2006-28 Human Cord Blood Transplantation in Advanced Hematological Malignancies
Status: Enrolling
Updated: 10/23/2015
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Click here to add this to my saved trials
UARK 2009-32 Compassionate Use Study of Carfilzomib
Compassionate Use Study of Carfilzomib for Patients With Relapsing or Resistant Multiple Myeloma
Status: Enrolling
Updated:  10/23/2015
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
UARK 2009-32 Compassionate Use Study of Carfilzomib
Compassionate Use Study of Carfilzomib for Patients With Relapsing or Resistant Multiple Myeloma
Status: Enrolling
Updated: 10/23/2015
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Click here to add this to my saved trials
Romiplostim in Treating Hepatitis C-Infected Patients With Thrombocytopenia
A Double-Blind, Placebo-controlled Phase II Study to Assess the Efficacy and Safety of Romiplostim, Administered Once Weekly to Thrombocytopenic Hepatitis C (HCV) Infected Subjects Who Are Not Candidates for Antiviral Treatment With Pegylated Interferon and Ribavirin Due to Persistent Thrombocytopenia
Status: Enrolling
Updated:  10/24/2015
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Romiplostim in Treating Hepatitis C-Infected Patients With Thrombocytopenia
A Double-Blind, Placebo-controlled Phase II Study to Assess the Efficacy and Safety of Romiplostim, Administered Once Weekly to Thrombocytopenic Hepatitis C (HCV) Infected Subjects Who Are Not Candidates for Antiviral Treatment With Pegylated Interferon and Ribavirin Due to Persistent Thrombocytopenia
Status: Enrolling
Updated: 10/24/2015
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety and Efficacy Study to Compare Uniplas With Cryosupernatant Plasma in Thrombotic Thrombocytopenic Purpura (TTP)
A Blinded Non-inferiority Study to Compare Uniplas With Cryosupernatant Plasma in Thrombotic Thrombocytopenic Purpura (TTP)
Status: Enrolling
Updated:  10/24/2015
Contact Octapharma for Facility Details
mi
from
Centreville, VA
Safety and Efficacy Study to Compare Uniplas With Cryosupernatant Plasma in Thrombotic Thrombocytopenic Purpura (TTP)
A Blinded Non-inferiority Study to Compare Uniplas With Cryosupernatant Plasma in Thrombotic Thrombocytopenic Purpura (TTP)
Status: Enrolling
Updated: 10/24/2015
Contact Octapharma for Facility Details
mi
from
Centreville, VA
Click here to add this to my saved trials
Donor Enhancement With Plerixafor Post Myeloablative Allogeneic Transplant
A Phase I/II Study: Enhancing Donor Hematopoietic Cell Engraftment With Plerixafor in Myeloablative Allogeneic Hematopoietic Cell Transplantation
Status: Enrolling
Updated:  10/26/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Donor Enhancement With Plerixafor Post Myeloablative Allogeneic Transplant
A Phase I/II Study: Enhancing Donor Hematopoietic Cell Engraftment With Plerixafor in Myeloablative Allogeneic Hematopoietic Cell Transplantation
Status: Enrolling
Updated: 10/26/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Donor Enhancement With Plerixafor Post Myeloablative Allogeneic Transplant
A Phase I/II Study: Enhancing Donor Hematopoietic Cell Engraftment With Plerixafor in Myeloablative Allogeneic Hematopoietic Cell Transplantation
Status: Enrolling
Updated:  10/26/2015
Medical University of South Carolina
mi
from
Charleston, SC
Donor Enhancement With Plerixafor Post Myeloablative Allogeneic Transplant
A Phase I/II Study: Enhancing Donor Hematopoietic Cell Engraftment With Plerixafor in Myeloablative Allogeneic Hematopoietic Cell Transplantation
Status: Enrolling
Updated: 10/26/2015
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
City of Hope National Medical Center
mi
from
Duarte, CA
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
City of Hope National Medical Center
mi
from
Duarte, CA
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
City of Hope
mi
from
Duarte, CA
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
City of Hope
mi
from
Duarte, CA
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
Rocky Mountain Cancer Center
mi
from
Denver, CO
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
Rocky Mountain Cancer Center
mi
from
Denver, CO
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
Georgetown University Medical Center
mi
from
Washington,
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
Georgetown University Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
Georgetown University Hospital
mi
from
Washington,
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
Georgetown University Hospital
mi
from
Washington,
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
Lombardi Cancer Center
mi
from
Washington,
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
Lombardi Cancer Center
mi
from
Washington,
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
The George Washington University Medical Faculty Associates (Gwmfa)
mi
from
Washington,
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
The George Washington University Medical Faculty Associates (Gwmfa)
mi
from
Washington,
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
The Emory Clinic
mi
from
Atlanta, GA
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
The Emory Clinic
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
Emory University Hospital
mi
from
Atlanta, GA
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
Emory University Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
Investigational Drug Service (Drug Ship)
mi
from
Atlanta, GA
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
Investigational Drug Service (Drug Ship)
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
Winship Cancer Institute
mi
from
Atlanta, GA
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
Winship Cancer Institute
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
Oncology Specialists, S.C.
mi
from
Niles, IL
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
Oncology Specialists, S.C.
mi
from
Niles, IL
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
Oncology Specialists, SC
mi
from
Park Ridge, IL
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
Oncology Specialists, SC
mi
from
Park Ridge, IL
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
Franciscan St. Francis Health, Site
mi
from
Indianapolis, IN
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
Franciscan St. Francis Health, Site
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
Indiana Blood and Marrow Transplantation Research-Franciscan St Francis Health Center Inc.
mi
from
Indianapolis, IN
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
Indiana Blood and Marrow Transplantation Research-Franciscan St Francis Health Center Inc.
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
Indiana Blood and Marrow Transplantation Research
mi
from
Indianapolis, IN
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
Indiana Blood and Marrow Transplantation Research
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
LSU Health Sciences Center
mi
from
Shreveport, LA
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
LSU Health Sciences Center
mi
from
Shreveport, LA
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
Louisiana State University Health Sciences Center, Feist-Weiller Cancer Center
mi
from
Shreveport, LA
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
Louisiana State University Health Sciences Center, Feist-Weiller Cancer Center
mi
from
Shreveport, LA
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
University of Maryland Medical Center
mi
from
Baltimore, MD
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
University of Maryland Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
University of Maryland
mi
from
Baltimore, MD
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
Hudson Valley Hematology and Oncology Associates
mi
from
Hawthorne, NY
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
Hudson Valley Hematology and Oncology Associates
mi
from
Hawthorne, NY
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
Westchester Oncology Hematology Group, P.C.
mi
from
Hawthorne, NY
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
Westchester Oncology Hematology Group, P.C.
mi
from
Hawthorne, NY
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
New York Presbyterian Hospital (Cornell)
mi
from
New York, NY
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
New York Presbyterian Hospital (Cornell)
mi
from
New York, NY
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
New York-Presbyterian Hospital
mi
from
New York, NY
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
New York-Presbyterian Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
Weill Cornell Medical Center
mi
from
New York, NY
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
Weill Cornell Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
Weill-Cornell Medical College
mi
from
New York, NY
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
Weill-Cornell Medical College
mi
from
New York, NY
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
University of Rochester Cancer Center Pharmacy
mi
from
Rochester, NY
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
University of Rochester Cancer Center Pharmacy
mi
from
Rochester, NY
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
University of Rochester Medical Center Strong Memorial Hospital - James P. Wilmot Cancer Center
mi
from
Rochester, NY
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
University of Rochester Medical Center Strong Memorial Hospital - James P. Wilmot Cancer Center
mi
from
Rochester, NY
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
Westchester Medical Center
mi
from
Valhalla, NY
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
Westchester Medical Center
mi
from
Valhalla, NY
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
M.D. Anderson Cancer Center
mi
from
Houston, TX
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
The University Of Texas
mi
from
Houston, TX
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
The University Of Texas
mi
from
Houston, TX
Click here to add this to my saved trials